Regular Tai Chi Chuan exercise may retard bone loss in postmenopausal women: A case-control study

2002 ◽  
Vol 83 (10) ◽  
pp. 1355-1359 ◽  
Author(s):  
Ling Qin ◽  
Szeki Au ◽  
Wingyee Choy ◽  
Pingchung Leung ◽  
Marus Neff ◽  
...  
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women ◽  
Tai Chi ◽  
Case Control Study ◽  
Case Control ◽  
Tai Chi Chuan ◽  
Control Study

scholarly journals The role of Tai Chi Chuan exercise on osteoporosis prevention and treatment in postmenopausal women

2011 ◽  
Vol 1 (1) ◽  
pp. 10
Author(s):  
Haiyan Chen
Keyword(s):  
Bone Loss ◽  
Postmenopausal Women ◽  
Tai Chi ◽  
Weight Bearing ◽  
Depression And Anxiety ◽  
Osteoporosis Prevention ◽  
Mineral Density ◽  
Cross Sectional ◽  
Tai Chi Chuan

Osteoporosis is a disease characterized by fragile bones and high susceptibility to low trauma fractures. Tai Chi, an ancient Chinese mind-body exercise that is reported to enhance muscle function, balance and flexibility, and to reduce pain, depression and anxiety, may safely and effectively be used to prevent or treat osteoporosis. The aim of this review is to evaluate the evidence for Tai Chi as an intervention to reduce rate of bone loss in postmenopausal women. A literature search on randomized controlled trials (RCTs), prospective cohort studies, and cross-sectional studies that included Tai Chi as an intervention, and had at least 1 outcome related to measurement of bone metabolism were identified in PubMed/Medline. Twenty-one controlled studies were identified in the database, which suggested Tai Chi slowed down the loss of bone mineral density in most postmenopausal women, improved balance and strength, relieves pain from arthritis, and improved mental strength so they can cope better with chronic diseases. Regular Tai Chi Chuan exercise is beneficial for retarding bone loss in the weight-bearing bones of postmenopausal women.

scholarly journals Lifetime alcohol consumption and breast cancer: a case–control study in Finland

2000 ◽  
Vol 3 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Satu Männistö ◽  
Mikko Virtanen ◽  
Vesa Kataja ◽  
Matti Uusitupa ◽  
Pirjo Pietinen
Keyword(s):  
Breast Cancer ◽  
Alcohol Consumption ◽  
Postmenopausal Women ◽  
Case Control Study ◽  
Premenopausal Women ◽  
Case Control ◽  
Total Lifetime ◽  
Increased Risk ◽  
Control Study ◽  
Current Alcohol

AbstractObjectiveTo study the association between lifetime alcohol consumption and the risk of breast cancer.Design and settingA case–control study carried out in eastern Finland. Information about alcohol consumption was obtained by two methods: a self-administered food frequency questionnaire (FFQ) including alcohol consumption during the previous 12 months, and a lifetime alcohol consumption questionnaire (AQ) which was administered by the study nurse.SubjectsThe study consisted of 301 breast cancer cases (25–75 years old) and 443 population controls.ResultsThe subjects reported higher current alcohol consumption in the AQ compared to the FFQ. According to the AQ, premenopausal cases consumed on average 28 g and controls 24 g alcohol week−1; in postmenopausal women the values were 15 and 14 g, respectively. About 30% of premenopausal and 60% of postmenopausal women were classified as non-drinkers. The correlation for current alcohol consumption between the FFQ and the AQ was 0.80 in premenopausal women but only 0.40 in postmenopausal women. Current alcohol consumption seemed to influence the reporting of total lifetime alcohol consumption. Current alcohol consumption was not associated with the risk of breast cancer either in premenopausal or postmenopausal women; neither were associations found between alcohol consumption at age of first use, use before the age of 30, or total lifetime alcohol consumption and the risk of breast cancer.ConclusionsOn average, one to three drinks per week did not increase the risk of breast cancer in this study. Consumption levels were, however, too low to exclude increased risk with high regular consumption. Further research is necessary on lifetime alcohol consumption.

scholarly journals Isoflavone in Postmenopausal Women - Are They Really Effective? A Prospective Case Control Study.

2013 ◽  
Vol 7 (1) ◽  
pp. 11-14 ◽  
Author(s):  
TS Bag ◽  
Amit Kyal ◽  
DP Saha ◽  
R Dutta ◽  
S Mondal
Keyword(s):  
Blood Pressure ◽  
Postmenopausal Women ◽  
Case Control Study ◽  
Case Control ◽  
Menopausal Symptoms ◽  
Kupperman Index ◽  
Group A ◽  
Group B ◽  
Control Study ◽  
Prospective Case Control Study

A prospective case control study was conducted at Medical College, Kolkata with the aim of evaluating the role of isoflavone( a class of phytoestrogen –plant compounds having the beneficial effects of estrogen but lesser risks and side effects) in postmenopausal women. 100 postmenopausal women (those who underwent total abdominal hysterectomy and bilateral salpingooopherectomy for different benign indications, aged between 40-50 years and who were menstruating before operation) were alternately distributed into two groups-Group A (n=50, received 60mg of isoflavone and 500mg of calcium per day for 6 months) and Group B (n=50, received 500mg of calcium per day only for 6 months). To evaluate the menopausal symptoms, the menopausal Kupperman index questionnaire was applied. Other outcomes measured were body mass index, blood pressure and lipid profile. Menopausal symptoms in Group A(those using isoflavones) were lower compared to Group B. The present study showed that Kupperman index decreased significantly in Group A (from 28.48 ± 2.03 to 16.32 ± 1.06 i.e. 45% decline) compared to Group B (from 24.56 ± 1.52 to 18.44 ± 1.11 i.e. 25% decline). No differences in blood pressure or body mass index were found during treatment between the two groups. . In our study total cholesterol, triglycerides and low-density lipoproteins (LDL) decreased significantly in Group A compared to Group B. Therefore our clinical study indicates that isoflavone can be an invaluable resource for postmenopausal women for combating menopausal symptoms. Nepal Journal of Obstetrics and Gynaecology / Vol 7 / No. 1 / Issue 13 / Jan- June, 2012 / 11-14 DOI: http://dx.doi.org/10.3126/njog.v7i1.8826

scholarly journals Plasma Adiponectin and the Risk of Hypertension in White and Black Postmenopausal Women

2012 ◽  
Vol 58 (10) ◽  
pp. 1438-1445 ◽  
Author(s):  
Lu Wang ◽  
JoAnn E Manson ◽  
J Michael Gaziano ◽  
Simin Liu ◽  
Barbara Cochrane ◽  
...  
Keyword(s):  
Black Women ◽  
Postmenopausal Women ◽  
White Women ◽  
Case Control Study ◽  
Plasma Concentrations ◽  
Case Control ◽  
Inverse Association ◽  
Plasma Adiponectin ◽  
Nested Case Control ◽  
Control Study

Abstract BACKGROUND Adiponectin may have a protective role in the development of obesity-related metabolic and vascular disorders, including hypertension. We conducted a prospective, nested case control study to investigate the relation between baseline plasma adiponectin, measures of adiposity, and subsequent risk of hypertension. METHODS We selected 400 white and 400 black postmenopausal women, age <70 years, who developed incident hypertension during 5.9-year follow-up and an equal number of age- and race-matched controls in the Women's Health Initiative Observational Study. We measured plasma concentrations of total adiponectin in their baseline blood samples. RESULTS In crude matched models, plasma adiponectin was inversely associated with risk of hypertension among both white and black women. The association appeared to be nonlinear in white women but dose related in black women. Adjustment for lifestyle factors, measures of obesity, and obesity-related clinical factors attenuated these associations. The multivariable relative risk (95% CI) of hypertension across increasing quartiles of plasma adiponectin were 1.00, 0.98 (0.66–1.46), 0.63 (0.41–0.97), and 0.92 (0.60–1.42) in white women (Ptrend: 0.38) and 1.00, 0.96 (0.64–1.46), 0.83 (0.53–1.29), and 0.58 (0.36–0.94) in black women (Ptrend: 0.02). Further adjustment for inflammatory markers and endothelial markers eliminated the association in white, but not black, women. CONCLUSIONS In this prospective, nested case control study, we found an inverse association between plasma adiponectin and risk of hypertension in white and black postmenopausal women. The reduced risk of hypertension was limited to only intermediate concentrations of adiponectin in white women whereas it was graded across quartiles of adiponectin in black women.

Sign in / Sign up

Export Citation Format

Share Document